Comment
doi: 10.1016/S0140-6736(15)01235-0.
Defining new standards of care for men with prostate cancer
Affiliations
- PMID: 27025318
- DOI: 10.1016/S0140-6736(15)01235-0
Item in Clipboard
Comment
Defining new standards of care for men with prostate cancer
Lancet.
.
Free article
No abstract available
Comment on
-
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
Similar articles
-
Prostate cancer: Changing standard of care in hormone-sensitive disease.Nat Rev Urol. 2016 Feb;13(2):61. doi: 10.1038/nrurol.2016.4. Epub 2016 Jan 20. Nat Rev Urol. 2016. PMID: 26787390 No abstract available.
-
STAMPEDE trial and patients with non-metastatic prostate cancer.Lancet. 2016 Jul 16;388(10041):234-5. doi: 10.1016/S0140-6736(16)31038-8. Lancet. 2016. PMID: 27479564 No abstract available.
-
STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.Lancet. 2016 Jul 16;388(10041):235-6. doi: 10.1016/S0140-6736(16)31041-8. Lancet. 2016. PMID: 27479566 No abstract available.
-
[Optimal treatment for elderly high-risk prostate cancer patients].Gan To Kagaku Ryoho. 2007 Mar;34(3):387-92. Gan To Kagaku Ryoho. 2007. PMID: 17353629 Review. Japanese.
-
[Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].Vopr Onkol. 1998;44(5):537-40. Vopr Onkol. 1998. PMID: 9884710 Review. Russian.
Cited by
-
The Role of Yes-Associated Protein in Inflammatory Diseases and Cancer.MedComm (2020). 2025 Mar 10;6(3):e70128. doi: 10.1002/mco2.70128. eCollection 2025 Mar. MedComm (2020). 2025. PMID: 40066231 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
